• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒突变株的传染性与致死率:与流感相比。

Infectivity versus fatality of SARS-CoV-2 mutations and influenza.

机构信息

College of Mathematical Sciences, Harbin Engineering University, Harbin, Heilongjiang, 150001, China.

Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.

出版信息

Int J Infect Dis. 2022 Aug;121:195-202. doi: 10.1016/j.ijid.2022.05.031. Epub 2022 May 15.

DOI:10.1016/j.ijid.2022.05.031
PMID:35584743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9107628/
Abstract

OBJECTIVES

Because of the spread of the Omicron variant, many countries have experienced COVID-19 case numbers unseen since the start of the pandemic. We aimed to compare the epidemiological characteristics of Omicron with previous variants and different strains of influenza to provide context for public health responses.

METHODS

We developed transmission models for SARS-CoV-2 variants and influenza, in which transmission, death, and vaccination rates were taken to be time-varying. We fit our model based on publicly available data in South Africa, the United States, and Canada. We used this model to evaluate the relative transmissibility and mortality of Omicron compared with previous variants and influenza.

RESULTS

We found that Omicron is more transmissible and less fatal than both seasonal and 2009 H1N1 influenza and the Delta variant; these characteristics make Omicron epidemiologically more similar to influenza than it is to Delta. We estimate that as of February 7, 2022, booster doses have prevented 4.29×10 and 1.14×10 Omicron infections in the United States and Canada, respectively.

CONCLUSION

Our findings indicate that the high infectivity of Omicron will keep COVID-19 endemic, similar to influenza. However, because of Omicron's lower fatality rate, our work suggests that human populations living with SARS-CoV-2 are most likely.

摘要

目的

由于奥密克戎变异株的传播,许多国家的 COVID-19 病例数达到了大流行开始以来从未见过的水平。我们旨在比较奥密克戎与之前的变异株和不同流感株的流行病学特征,为公共卫生应对措施提供背景信息。

方法

我们开发了 SARS-CoV-2 变异株和流感的传播模型,其中传播、死亡和疫苗接种率被视为时变的。我们根据南非、美国和加拿大的公开数据对模型进行了拟合。我们使用该模型评估了奥密克戎与之前的变异株和流感相比的相对传染性和死亡率。

结果

我们发现,奥密克戎比季节性和 2009 年 H1N1 流感以及德尔塔变异株更具传染性和致命性;这些特征使奥密克戎在流行病学上与流感更为相似,而不是与德尔塔相似。我们估计,截至 2022 年 2 月 7 日,在美国和加拿大,加强针分别预防了 4.29×10 和 1.14×10 例奥密克戎感染。

结论

我们的研究结果表明,奥密克戎的高传染性将使 COVID-19 继续流行,类似于流感。然而,由于奥密克戎的死亡率较低,我们的研究表明,与 SARS-CoV-2 共存的人群很可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/4ebf21b143d1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/ecac6cf1a96f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/49494c7dfdef/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/edea0732f16b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/4ebf21b143d1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/ecac6cf1a96f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/49494c7dfdef/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/edea0732f16b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c56/9107628/4ebf21b143d1/gr4_lrg.jpg

相似文献

1
Infectivity versus fatality of SARS-CoV-2 mutations and influenza.新冠病毒突变株的传染性与致死率:与流感相比。
Int J Infect Dis. 2022 Aug;121:195-202. doi: 10.1016/j.ijid.2022.05.031. Epub 2022 May 15.
2
Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.与南非先前的变异株相比,奥密克戎变异株的感染病死率降低。
Int J Infect Dis. 2022 Jul;120:146-149. doi: 10.1016/j.ijid.2022.04.029. Epub 2022 Apr 21.
3
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.
4
Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics.比较 2009 年甲型 H1N1 流感和 2022 年 SARS-CoV-2 大流行,对年龄<65 岁的患者进行回顾性观察队列研究,以区分 COVID-19 和季节性流感。
Front Cell Infect Microbiol. 2023 Jul 18;13:1179552. doi: 10.3389/fcimb.2023.1179552. eCollection 2023.
5
Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.住院患者中阿尔法、德尔塔、奥密克戎SARS-CoV-2变种及流感病毒的空气传播病毒排放情况。
J Med Virol. 2023 Apr;95(4):e28748. doi: 10.1002/jmv.28748.
6
SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.SARS-CoV-2 B.1.1.529(奥密克戎)变异株-美国,2021 年 12 月 1 日-8 日。
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734. doi: 10.15585/mmwr.mm7050e1.
7
Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity.关注的奥密克戎 SARS-CoV-2 变体:对其传染性、免疫逃逸、再感染和严重性的综述。
Medicine (Baltimore). 2022 May 13;101(19):e29165. doi: 10.1097/MD.0000000000029165.
8
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
9
Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.古巴检测到严重急性呼吸综合征冠状病毒2(SARS-CoV-2)B.1.1.529(奥密克戎)变种后的前八周患者的流行病学特征
MEDICC Rev. 2022 Oct 31;24(3-4):18-23. doi: 10.37757/MR2022.V24.N3-4.6.
10
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.

引用本文的文献

1
Infectivity and fatality of influenza in pre- and post-COVID-19 pandemic year.2019年新冠疫情大流行前后流感的传染性和致死率。
PLoS Comput Biol. 2025 Jul 8;21(7):e1013229. doi: 10.1371/journal.pcbi.1013229. eCollection 2025 Jul.
2
Prevention and control of infectious disease transmission in subways: an improved susceptible-exposed-infected-recovered model.地铁中传染病传播的预防与控制:一种改进的易感-暴露-感染-康复模型
Front Public Health. 2024 Dec 12;12:1454450. doi: 10.3389/fpubh.2024.1454450. eCollection 2024.
3
Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.

本文引用的文献

1
A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.一种简单的模型,用于估计 SARS-COV-2 的 Beta、Delta 和 Omicron 变体在南非的传播能力。
Math Biosci Eng. 2022 Jul 22;19(10):10361-10373. doi: 10.3934/mbe.2022485.
2
Omicron adopts a different strategy from Delta and other variants to adapt to host.奥密克戎采用了与德尔塔及其他变体不同的策略来适应宿主。
Signal Transduct Target Ther. 2022 Feb 10;7(1):45. doi: 10.1038/s41392-022-00903-5.
3
Equitable access to COVID-19 vaccines makes a life-saving difference to all countries.
基于元 SEIRS 模型预测 SARS-CoV-2 感染病例。
Epidemiol Infect. 2024 Nov 18;152:e144. doi: 10.1017/S0950268824001274.
4
The spatial-temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022.COVID-19 病死率的时空变化及其影响因素:2021 年 2 月至 2022 年 5 月 30 个国家的全球研究。
Epidemiol Infect. 2024 Oct 17;152:e124. doi: 10.1017/S0950268824000852.
5
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.轻度至中度 COVID-19 患者中根据 SARS-CoV-2 突变的药物治疗现状和临床结局:一项回顾性单中心研究。
BMC Infect Dis. 2024 Sep 3;24(1):871. doi: 10.1186/s12879-024-09765-4.
6
The Clinical Severity of COVID-19 Variants of Concern: Retrospective Population-Based Analysis.关注的 COVID-19 变异株的临床严重程度:回顾性基于人群的分析。
JMIR Public Health Surveill. 2024 Aug 27;10:e45513. doi: 10.2196/45513.
7
Clinical and Genomic Perspective of SARS CoV-2 Infection in Liver Disease Patients: A Single-Centre Retrospective Study.肝脏疾病患者中严重急性呼吸综合征冠状病毒 2 感染的临床和基因组观点:一项单中心回顾性研究。
Curr Microbiol. 2024 Aug 8;81(9):301. doi: 10.1007/s00284-024-03786-7.
8
Risk Index of Regional Infection Expansion of COVID-19: Moving Direction Entropy Study Using Mobility Data and Its Application to Tokyo.COVID-19 区域感染扩张风险指数:使用移动性数据的移动方向熵研究及其在东京的应用。
JMIR Public Health Surveill. 2024 Aug 21;10:e57742. doi: 10.2196/57742.
9
Public acceptance of COVID-19 control measures and associated factors during Omicron-dominant period in China: a cross-sectional survey.公众对奥密克戎变异株流行期间中国新冠防控措施的接受程度及其影响因素:一项横断面调查。
BMC Public Health. 2024 Feb 21;24(1):543. doi: 10.1186/s12889-024-17646-3.
10
Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.长期疫苗接种策略以减轻 SARS-CoV-2 传播的影响:建模研究。
PLoS Med. 2023 Nov 28;20(11):e1004195. doi: 10.1371/journal.pmed.1004195. eCollection 2023 Nov.
公平获取 COVID-19 疫苗对所有国家都有着生死攸关的意义。
Nat Hum Behav. 2022 Feb;6(2):207-216. doi: 10.1038/s41562-022-01289-8. Epub 2022 Jan 31.
4
Emergence of Omicron third lineage BA.3 and its importance.奥密克戎第三个谱系BA.3的出现及其重要性。
J Med Virol. 2022 May;94(5):1808-1810. doi: 10.1002/jmv.27601. Epub 2022 Jan 23.
5
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.
6
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.
7
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.奥密克戎能广泛但不完全地逃避辉瑞 BNT162b2 的中和作用。
Nature. 2022 Feb;602(7898):654-656. doi: 10.1038/s41586-021-04387-1. Epub 2021 Dec 23.
8
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.广谱中和抗体可克服 SARS-CoV-2 奥密克戎抗原漂移。
Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.
9
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.奥密克戎逃避了大多数现有的 SARS-CoV-2 中和抗体。
Nature. 2022 Feb;602(7898):657-663. doi: 10.1038/s41586-021-04385-3. Epub 2021 Dec 23.
10
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.奥密克戎变异株(B.1.1.529):传染性、疫苗突破和抗体耐药性。
J Chem Inf Model. 2022 Jan 24;62(2):412-422. doi: 10.1021/acs.jcim.1c01451. Epub 2022 Jan 6.